OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 14.89% | 1.89% | -31.52% | 36.94% | -1.01% |
| Total Depreciation and Amortization | -96.65% | 2.08% | 1.32% | 2.40% | 86.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -148.81% | 123.21% | 38.59% | -57.94% | 59.22% |
| Change in Net Operating Assets | 43.02% | 5.43% | 101.00% | 120.27% | -66.53% |
| Cash from Operations | -7.91% | 11.42% | -29.50% | 46.66% | -1.47% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30% | -27.98% | 41.96% | -0.73% | -0.74% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | 80.77% | 36.59% | 60.58% | -112.24% | 82.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,025.31% | -206.22% | -297.17% | 199.07% | -138.77% |
| Cash from Financing | 1,410.54% | -42.86% | 35.46% | -105.24% | 50.65% |
| Foreign Exchange rate Adjustments | 176.92% | -369.95% | 47.41% | -11.88% | -320.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.85% | 8.47% | -24.76% | 45.08% | -2.26% |